# Sagent Pharmaceuticals – FDA Inspection, Aug 19, 2015

Source: https://www.keypedia.com/records/fda_inspections/sagent-pharmaceuticals/9265d709-d972-4907-92dd-f1ffa3092b89
Source feed: FDA_Inspections

> FDA inspection 940865 of Sagent Pharmaceuticals, August 19, 2015. Classification: No Action Indicated (NAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 940865
- Company Name: Sagent Pharmaceuticals
- Inspection Date: 2015-08-19
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1231342 - 2024-09-20
- [FDA Inspection 1114257 - 2019-12-18](https://www.keypedia.com/records/fda_inspections/sagent-pharmaceuticals/be17d563-e1d8-468f-8c7e-cc171fc26d4a)
- [FDA Inspection 1066792 - 2018-09-24](https://www.keypedia.com/records/fda_inspections/sagent-pharmaceuticals/db728d61-25fd-4a30-a263-c89969ba55cc)
- [FDA Inspection 782558 - 2012-05-11](https://www.keypedia.com/records/fda_inspections/sagent-pharmaceuticals/cf99e690-6aba-4034-85aa-0a8d5711bd0a)
- FDA Inspection 717757 - 2011-03-11

Company: https://www.keypedia.com/companies/sagent-pharmaceuticals/9b7830c1-51dd-4d82-8287-b320eff537fd

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
